Of note, genes displaying a strong negative correlation (r < − 0.4; n = 5) with COL6A1 were particularly expressed in both normal brain samples and low-grade gliomas relative to higher grade tumors. This evidence concerns the gene COL6A1 and central nervous system cancer.